Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Dose-Finding Study of Anagliptin in Type 2 Diabetes
NCT00532506Phase 2Completed
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anagliptin in type 2 diabetes mellitus (T2DM), sponsored by Sanwa Kagaku Kenkyusho Co., Ltd.. Status: completed.
02
Drugs
anagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00532506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532506.